A Study of Extending Relugolix Dosing Intervals Through Addition of Itraconazole or Ritonavir in Prostate Cancer Patients
Clinical trial NCT05679388 · TERMINATED
Trial details
- NCT number
- NCT05679388
- Sponsor
- University of Chicago
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-13
- Primary completion
- 2024-08-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.